Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TREAT-CAD: Aspirin vs Anticoagulation in Cervical Artery Dissection
NCT02046460Phase 3Completed
- Start
- Sep 2013
- Primary completion
- Jun 2019
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
Phase 3, randomised, open-label trial of aspirin in cervical artery dissection (2 arms). Primary endpoint: Composite of Cerebrovascular Ischemia, Major Hemorrhagic Events or Death at 3 months. Started Sep 2013; status: completed.
02
Drugs
aspirin
03
Conditions
cervical artery dissection
Beyond the preview
Go deeper on NCT02046460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02046460.